- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.50 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x CA: CALCIUM ION(Non-functional Binders)
- 2 x ADP: ADENOSINE-5'-DIPHOSPHATE(Non-covalent)
- 2 x PO4: PHOSPHATE ION(Non-functional Binders)
PO4.3: 6 residues within 4Å:- Chain A: V.183, S.246, R.247, A.248, D.249, K.302
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:D.249
- Water bridges: A:K.302, A:K.302
- Salt bridges: A:K.302
PO4.20: 6 residues within 4Å:- Chain B: V.183, S.246, R.247, A.248, D.249, K.302
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:D.249
- Water bridges: B:K.302, B:K.302
- Salt bridges: B:K.302
- 2 x MPD: (4S)-2-METHYL-2,4-PENTANEDIOL(Non-functional Binders)
MPD.4: 11 residues within 4Å:- Chain A: S.208, T.212, P.311, V.312, V.315, R.358
- Chain B: S.163, G.166, L.167, T.170
- Ligands: ACT.6
6 PLIP interactions:5 interactions with chain A, 1 interactions with chain B- Hydrophobic interactions: A:T.212, A:P.311, A:V.312
- Hydrogen bonds: A:R.358, A:R.358
- Water bridges: B:T.170
MPD.21: 11 residues within 4Å:- Chain A: S.163, G.166, L.167, T.170
- Chain B: S.208, T.212, P.311, V.312, V.315, R.358
- Ligands: ACT.23
6 PLIP interactions:5 interactions with chain B, 1 interactions with chain A- Hydrophobic interactions: B:T.212, B:P.311, B:V.312
- Hydrogen bonds: B:R.358, B:R.358
- Water bridges: A:T.170
- 2 x MRD: (4R)-2-METHYLPENTANE-2,4-DIOL(Non-functional Binders)
MRD.5: 6 residues within 4Å:- Chain A: L.227, G.228, I.229, V.230, A.240, E.243
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:L.227, A:A.240
- Hydrogen bonds: A:E.243
MRD.22: 6 residues within 4Å:- Chain B: L.227, G.228, I.229, V.230, A.240, E.243
3 PLIP interactions:3 interactions with chain B- Hydrophobic interactions: B:L.227, B:A.240
- Hydrogen bonds: B:E.243
- 20 x ACT: ACETATE ION(Non-functional Binders)
ACT.6: 7 residues within 4Å:- Chain A: N.310, P.311, V.312
- Chain B: L.48, R.141, D.146
- Ligands: MPD.4
Ligand excluded by PLIPACT.7: 3 residues within 4Å:- Chain A: N.195, E.197
- Chain B: R.31
Ligand excluded by PLIPACT.8: 6 residues within 4Å:- Chain A: E.18, M.19, T.20, P.21, V.22, R.301
Ligand excluded by PLIPACT.9: 1 residues within 4Å:- Chain A: E.18
Ligand excluded by PLIPACT.10: 4 residues within 4Å:- Chain A: L.6, T.7, S.8, F.283
Ligand excluded by PLIPACT.11: 4 residues within 4Å:- Chain A: L.6, F.283, L.288, R.353
Ligand excluded by PLIPACT.12: 5 residues within 4Å:- Chain A: D.334, R.336, P.337, T.338
- Chain B: R.387
Ligand excluded by PLIPACT.13: 4 residues within 4Å:- Chain A: T.25, A.39, K.156, N.179
Ligand excluded by PLIPACT.14: 1 residues within 4Å:- Chain A: V.22
Ligand excluded by PLIPACT.15: 5 residues within 4Å:- Chain A: C.152, V.153, L.154, A.155
- Chain B: S.385
Ligand excluded by PLIPACT.23: 7 residues within 4Å:- Chain A: L.48, R.141, D.146
- Chain B: N.310, P.311, V.312
- Ligands: MPD.21
Ligand excluded by PLIPACT.24: 3 residues within 4Å:- Chain A: R.31
- Chain B: N.195, E.197
Ligand excluded by PLIPACT.25: 6 residues within 4Å:- Chain B: E.18, M.19, T.20, P.21, V.22, R.301
Ligand excluded by PLIPACT.26: 1 residues within 4Å:- Chain B: E.18
Ligand excluded by PLIPACT.27: 4 residues within 4Å:- Chain B: L.6, T.7, S.8, F.283
Ligand excluded by PLIPACT.28: 4 residues within 4Å:- Chain B: L.6, F.283, L.288, R.353
Ligand excluded by PLIPACT.29: 5 residues within 4Å:- Chain A: R.387
- Chain B: D.334, R.336, P.337, T.338
Ligand excluded by PLIPACT.30: 4 residues within 4Å:- Chain B: T.25, A.39, K.156, N.179
Ligand excluded by PLIPACT.31: 1 residues within 4Å:- Chain B: V.22
Ligand excluded by PLIPACT.32: 5 residues within 4Å:- Chain A: S.385
- Chain B: C.152, V.153, L.154, A.155
Ligand excluded by PLIP- 2 x D95: Artesunate(Non-covalent)
D95.16: 12 residues within 4Å:- Chain A: M.9, D.10, F.13, I.14, L.17, L.320, R.336, P.337, I.339, Y.356, M.394, M.414
10 PLIP interactions:10 interactions with chain A- Hydrophobic interactions: A:D.10, A:F.13, A:F.13, A:R.336, A:I.339
- Hydrogen bonds: A:R.336
- Salt bridges: A:R.336, A:R.336, A:R.336, A:R.336
D95.33: 12 residues within 4Å:- Chain B: M.9, D.10, F.13, I.14, L.17, L.320, R.336, P.337, I.339, Y.356, M.394, M.414
10 PLIP interactions:10 interactions with chain B- Hydrophobic interactions: B:D.10, B:F.13, B:F.13, B:R.336, B:I.339
- Hydrogen bonds: B:R.336
- Salt bridges: B:R.336, B:R.336, B:R.336, B:R.336
- 2 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kasaragod, V.B. et al., Elucidating the Molecular Basis for Inhibitory Neurotransmission Regulation by Artemisinins. Neuron (2019)
- Release Date
- 2019-01-16
- Peptides
- Gephyrin: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.50 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x CA: CALCIUM ION(Non-functional Binders)
- 2 x ADP: ADENOSINE-5'-DIPHOSPHATE(Non-covalent)
- 2 x PO4: PHOSPHATE ION(Non-functional Binders)
- 2 x MPD: (4S)-2-METHYL-2,4-PENTANEDIOL(Non-functional Binders)
- 2 x MRD: (4R)-2-METHYLPENTANE-2,4-DIOL(Non-functional Binders)
- 20 x ACT: ACETATE ION(Non-functional Binders)
- 2 x D95: Artesunate(Non-covalent)
- 2 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kasaragod, V.B. et al., Elucidating the Molecular Basis for Inhibitory Neurotransmission Regulation by Artemisinins. Neuron (2019)
- Release Date
- 2019-01-16
- Peptides
- Gephyrin: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A